首頁 > 市場調查報告書 > 材料

市場調查報告書

商品編碼

1532007

2024 年哺乳動物細胞發酵技術全球市場報告

Mammalian Cell Fermentation Technology Global Market Report 2024

出版日期: 2024年08月12日 | 出版商:

The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

哺乳動物細胞發酵技術市場規模預計在未來幾年將快速成長。 2028年，將以11.8%的年複合成長率（CAGR）成長至801.6億美元。預測期內預期成長的因素包括慢性病盛行率增加、跨國公司投資增加、慢性病發生頻率增加、先進生物加工技術的採用增加以及新的重組技術，其中包括對蛋白質研發的投資增加。的需求增加。這段時期的主要趨勢包括細胞培養和反應器設計的技術進步、下一代生物加工技術的開發、多組體學方法的整合以及技術主導的自動化。

生技藥品需求的增加預計將在未來幾年推動哺乳動物細胞發酵技術市場的成長。生技藥品是從活生物體或其成分中提取的藥物，通常用於治療癌症、自體免疫疾病和感染疾病等疾病。生物技術的進步、其治療流行慢性病的有效性、監管部門的核准以及研發投資的增加推動了對生技藥品的需求不斷成長。哺乳動物細胞發酵技術對於製造複雜的生技藥品和滿足日益成長的個人化和標靶治療的需求至關重要。其可擴展性、多功能性和生產高品質蛋白質的能力促進了生物製藥行業的創新。例如，美國國家醫學圖書館在 2024 年 2 月報告稱，食品藥物管理局(FDA) 將在 2023 年核准55 種新藥，其中包括 29 種新化學實體 (NCE) 和 25 種新生物製藥( NBE)。因此，對生技藥品的需求不斷成長正在推動哺乳動物細胞發酵技術市場的擴大。

哺乳動物細胞發酵技術市場的領先公司正在開發哺乳動物細胞培養等創新技術，以鞏固其市場地位。哺乳動物細胞培養是生物製造、研究和再生醫學的重要工具，能夠生產治療性蛋白質、疫苗以及功能性細胞和組織類似物。例如，2021年2月，美國生技公司Culture Biosciences宣布推出用於哺乳動物細胞培養的雲生物反應器。這項突破性技術為可擴展的細胞培養研究提供了一個完整的雲端基礎的平台，是生物加工領域的重大進步。此雲端反應器利用遠端監控技術，可在任何有網路存取的地方實現即時資料分析和決策，為生物製程和生物製造開發提供擴充性、靈活性和增強協作。

全球哺乳動物細胞發酵技術市場：按類型分類的表現與預測，2018-2023、2023-2028F、2033F
中國倉鼠卵巢細胞發酵
人類胎腎細胞發酵
小倉鼠腎細胞發酵
小鼠骨髓瘤細胞的發酵
其他類型
全球哺乳動物細胞發酵技術市場：按應用分類的表現與預測，2018-2023、2023-2028F、2033F
單株抗體
重組蛋白
疫苗
荷爾蒙
酵素
其他用途
全球哺乳動物細胞發酵技術市場：依最終用途分類的表現與預測，2018-2023、2023-2028F、2033F
生物製藥公司
合約研究組織和合約開發製造組織
學術研究所

第 7 章區域/國家分析

全球哺乳動物細胞發酵技術市場：按地區分類的表現與預測，2018-2023、2023-2028F、2033F
全球哺乳動物細胞發酵技術市場：按國家分類的表現和預測，2018-2023、2023-2028F、2033F

第8章亞太市場

第9章中國市場

第10章印度市場

第11章日本市場

第12章澳洲市場

第13章印尼市場

第14章韓國市場

第15章西歐市場

第16章英國市場

第17章德國市場

第18章法國市場

第19章義大利市場

第20章西班牙市場

第21章東歐市場

第22章俄羅斯市場

第23章北美市場

第24章美國市場

第25章加拿大市場

第26章南美洲市場

第27章巴西市場

第28章中東市場

第29章非洲市場

第30章競爭格局及公司概況

哺乳動物細胞發酵技術市場：競爭格局
哺乳動物細胞發酵技術市場：公司簡介
- AbbVie Inc.
- Thermo Fisher Scientific Inc
- AstraZeneca PLC
- Roche Holdings Inc.
- Merck KGaA

第31章其他重大及創新企業

AGC Group
Lonza Group Ltd.
Boehringer Ingelheim GmbH
Catalent Inc.
Sartorius AG
Samsung Biologics Co. Ltd.
WuXi Biologics
Biocon Limited
Eppendorf AG
KBI Biopharma Inc.
Fujifilm Diosynth Biotechnologies
Avid Bioservices Inc.
BiOZEEN
Nordmark Pharma GmbH
Scorpius BioManufacturing Inc.

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章重大併購

第35章前瞻性與潛力分析

第36章附錄

簡介目錄

Product Code: r18916

Mammalian cell fermentation technology refers to the process of cultivating mammalian cells under controlled conditions to produce biopharmaceuticals, vaccines, or other biological products. This technology involves optimizing cell growth and protein expression in bioreactors or fermenters, ensuring the production of high-quality and consistent yields of desired therapeutic proteins or substances.

The main types of mammalian cell fermentation technology include Chinese hamster ovary (CHO) cell fermentation, human embryonic kidney (HEK) cell fermentation, baby hamster kidney (BHK) cell fermentation, murine myeloma cell fermentation, and other types. Chinese hamster ovary (CHO) cell fermentation is a biotechnological process used in the production of therapeutic proteins, such as monoclonal antibodies and recombinant proteins. The various applications of mammalian cell fermentation technology include monoclonal antibodies, recombinant proteins, vaccines, hormones, enzymes, and other products. The end-users of this technology include biopharmaceutical companies, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), and academic and research institutes.

The mammalian cell fermentation technology market research report is one of a series of new reports from The Business Research Company that provides mammalian cell fermentation technology market statistics, including mammalian cell fermentation technology industry global market size, regional shares, competitors with a mammalian cell fermentation technology market share, detailed mammalian cell fermentation technology market segments, market trends, and opportunities, and any further data you may need to thrive in the mammalian cell fermentation technology industry. This mammalian cell fermentation technology research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The mammalian cell fermentation technology market size has grown rapidly in recent years. It will grow from $46.05 billion in 2023 to $51.29 billion in 2024 at a compound annual growth rate (CAGR) of 11.4%. The growth observed in the historic period can be attributed to several factors, including increased demand for biologics and biosimilars, a heightened focus on personalized medicine, an increased output of biopharmaceuticals, and a rising demand for scalable and effective cell culture methods.

The mammalian cell fermentation technology market size is expected to see rapid growth in the next few years. It will grow to $80.16 billion in 2028 at a compound annual growth rate (CAGR) of 11.8%. The expected growth in the forecast period can be attributed to several factors, including the increasing prevalence of chronic diseases, rising investments by multinational corporations, the growing frequency of chronic diseases, the increasing adoption of advanced bioprocessing techniques, rising investment in research and development of novel recombinant proteins, and the growing demand for cancer therapies. Major trends anticipated during this period include technological advancements in cell culture and bioreactor design, the development of next-generation bioprocessing technologies, the integration of multi-omics approaches, and technology-driven automation.

The increasing demand for biologics is anticipated to drive the growth of the mammalian cell fermentation technology market in the future. Biologics, which are medical products derived from living organisms or their components, are often used to treat diseases such as cancer, autoimmune disorders, and infectious diseases. The growing demand for biologics is driven by advancements in biotechnology, their effectiveness in treating prevalent chronic diseases, regulatory approvals, and increased investment in research and development. Mammalian cell fermentation technology is crucial for producing complex biologics, meeting the rising demand for personalized and targeted therapeutics. Its scalability, versatility, and ability to produce high-quality proteins foster innovation in the biopharmaceutical industry. For example, the National Library of Medicine reported in February 2024 that the Food and Drug Administration (FDA) approved 55 new drugs in 2023, including 29 new chemical entities (NCEs) and 25 new biological entities (NBEs), marking a 50% increase compared to the 37 approvals in 2022. Therefore, the growing demand for biologics is driving the expansion of the mammalian cell fermentation technology market.

Leading companies in the mammalian cell fermentation technology market are developing innovative technologies, such as mammalian cell culture, to bolster their market position. Mammalian cell culture is a vital tool in biomanufacturing, research, and regenerative medicine, enabling the production of therapeutic proteins, vaccines, and functional cells or tissue analogs. For instance, in February 2021, Culture Bioscience, a US-based biotechnology company, introduced cloud bioreactors for mammalian cell culture. This groundbreaking technology provides a fully cloud-based platform for scalable cell culture research, representing a significant advancement in bioprocessing. These cloud bioreactors utilize remote monitoring and control technologies to offer real-time data analysis and decision-making from any location with internet access, enhancing scalability, flexibility, and collaboration in bioprocess and biomanufacturing development.

In February 2024, Chrysea Limited, an Ireland-based biotechnology company, acquired Rodon Biologics from the Iberfar Group for an undisclosed amount. With this acquisition, Chrysea aims to strengthen its synthetic biology and biopharmaceutical development capabilities by integrating Rodon Biologics' expertise in protein engineering, cell-line development, precision fermentation, downstream processing, formulation, analytics, and production. Rodon Biologics, a Portugal-based manufacturer of biological products, operates in mammalian cell fermentation technology.

Major companies operating in the mammalian cell fermentation technology market are AbbVie Inc., Thermo Fisher Scientific Inc, AstraZeneca PLC, Roche Holdings Inc., Merck KGaA, AGC Group, Lonza Group Ltd., Boehringer Ingelheim GmbH, Catalent Inc., Sartorius AG, Samsung Biologics Co. Ltd., WuXi Biologics, Biocon Limited, Eppendorf AG, KBI Biopharma Inc., Fujifilm Diosynth Biotechnologies, Avid Bioservices Inc., BiOZEEN, Nordmark Pharma GmbH, Scorpius BioManufacturing Inc

North America was the largest region in the mammalian cell fermentation technology market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mammalian cell fermentation technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the mammalian cell fermentation technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mammalian cell fermentation technology market consists revenues earned by entities by providing services such as cell line development, process development, cell culture and fermentation, analytical and quality control services, and formulation and fill-finish services. The market value includes the value of related goods sold by the service provider or included within the service offering. The mammalian cell fermentation technology market also includes of sales of biosimilars, cell and gene therapy products, diagnostic enzymes and proteins, and therapeutic proteins. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Mammalian Cell Fermentation Technology Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mammalian cell fermentation technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mammalian cell fermentation technology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The mammalian cell fermentation technology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Chinese Hamster Ovary Cell Fermentation; Human Embryonic Kidney Cell Fermentation; Baby Hamster Kidney Cell Fermentation; Murine Myeloma Cell Fermentation; Other Types
2) By Application: Monoclonal Antibodies; Recombinant Proteins; Vaccines; Hormones; Enzymes; Other Applications
3) By End-Use: Biopharmaceutical Companies; Contract Research Organizations And Contract Development and Manufacturing Organizations; Academic And Research Institutes
Companies Mentioned: AbbVie Inc.; Thermo Fisher Scientific Inc; AstraZeneca PLC; Roche Holdings Inc.; Merck KGaA
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

1. Executive Summary

2. Mammalian Cell Fermentation Technology Market Characteristics

3. Mammalian Cell Fermentation Technology Market Trends And Strategies

4. Mammalian Cell Fermentation Technology Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Mammalian Cell Fermentation Technology Market Size and Growth

5.1. Global Mammalian Cell Fermentation Technology Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Mammalian Cell Fermentation Technology Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Mammalian Cell Fermentation Technology Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Mammalian Cell Fermentation Technology Market Segmentation

6.1. Global Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Chinese Hamster Ovary Cell Fermentation
Human Embryonic Kidney Cell Fermentation
Baby Hamster Kidney Cell Fermentation
Murine Myeloma Cell Fermentation
Other Types
6.2. Global Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Monoclonal Antibodies
Recombinant Proteins
Vaccines
Hormones
Enzymes
Other Applications
6.3. Global Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Biopharmaceutical Companies
Contract Research Organizations And Contract Development and Manufacturing Organizations
Academic And Research Institutes

7. Mammalian Cell Fermentation Technology Market Regional And Country Analysis

7.1. Global Mammalian Cell Fermentation Technology Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Mammalian Cell Fermentation Technology Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Mammalian Cell Fermentation Technology Market

8.1. Asia-Pacific Mammalian Cell Fermentation Technology Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Mammalian Cell Fermentation Technology Market

9.1. China Mammalian Cell Fermentation Technology Market Overview
9.2. China Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Mammalian Cell Fermentation Technology Market

10.1. India Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Mammalian Cell Fermentation Technology Market

11.1. Japan Mammalian Cell Fermentation Technology Market Overview
11.2. Japan Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Mammalian Cell Fermentation Technology Market

12.1. Australia Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Mammalian Cell Fermentation Technology Market

13.1. Indonesia Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Mammalian Cell Fermentation Technology Market

14.1. South Korea Mammalian Cell Fermentation Technology Market Overview
14.2. South Korea Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Mammalian Cell Fermentation Technology Market

15.1. Western Europe Mammalian Cell Fermentation Technology Market Overview
15.2. Western Europe Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Mammalian Cell Fermentation Technology Market

16.1. UK Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Mammalian Cell Fermentation Technology Market

17.1. Germany Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Mammalian Cell Fermentation Technology Market

18.1. France Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Mammalian Cell Fermentation Technology Market

19.1. Italy Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Mammalian Cell Fermentation Technology Market

20.1. Spain Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Mammalian Cell Fermentation Technology Market

21.1. Eastern Europe Mammalian Cell Fermentation Technology Market Overview
21.2. Eastern Europe Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Mammalian Cell Fermentation Technology Market

22.1. Russia Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Mammalian Cell Fermentation Technology Market

23.1. North America Mammalian Cell Fermentation Technology Market Overview
23.2. North America Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Mammalian Cell Fermentation Technology Market

24.1. USA Mammalian Cell Fermentation Technology Market Overview
24.2. USA Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Mammalian Cell Fermentation Technology Market

25.1. Canada Mammalian Cell Fermentation Technology Market Overview
25.2. Canada Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Mammalian Cell Fermentation Technology Market

26.1. South America Mammalian Cell Fermentation Technology Market Overview
26.2. South America Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Mammalian Cell Fermentation Technology Market

27.1. Brazil Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Mammalian Cell Fermentation Technology Market

28.1. Middle East Mammalian Cell Fermentation Technology Market Overview
28.2. Middle East Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Mammalian Cell Fermentation Technology Market

29.1. Africa Mammalian Cell Fermentation Technology Market Overview
29.2. Africa Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Mammalian Cell Fermentation Technology Market Competitive Landscape And Company Profiles

30.1. Mammalian Cell Fermentation Technology Market Competitive Landscape
30.2. Mammalian Cell Fermentation Technology Market Company Profiles
- 30.2.1. AbbVie Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Thermo Fisher Scientific Inc
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. AstraZeneca PLC
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Roche Holdings Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Merck KGaA
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Mammalian Cell Fermentation Technology Market Other Major And Innovative Companies

31.1. AGC Group
31.2. Lonza Group Ltd.
31.3. Boehringer Ingelheim GmbH
31.4. Catalent Inc.
31.5. Sartorius AG
31.6. Samsung Biologics Co. Ltd.
31.7. WuXi Biologics
31.8. Biocon Limited
31.9. Eppendorf AG
31.10. KBI Biopharma Inc.
31.11. Fujifilm Diosynth Biotechnologies
31.12. Avid Bioservices Inc.
31.13. BiOZEEN
31.14. Nordmark Pharma GmbH
31.15. Scorpius BioManufacturing Inc.

32. Global Mammalian Cell Fermentation Technology Market Competitive Benchmarking

33. Global Mammalian Cell Fermentation Technology Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Mammalian Cell Fermentation Technology Market

35. Mammalian Cell Fermentation Technology Market Future Outlook and Potential Analysis

35.1 Mammalian Cell Fermentation Technology Market In 2028 - Countries Offering Most New Opportunities
35.2 Mammalian Cell Fermentation Technology Market In 2028 - Segments Offering Most New Opportunities
35.3 Mammalian Cell Fermentation Technology Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies